+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 65Years
All Genders
ID07316127

Testing Immunoadsorption Treatment for Autoimmune Long COVID A Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial In Adults Aged 18 to 65

Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2026-01-05

70

Participants Needed

1

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Some people with long COVID experience serious symptoms like extreme fatigue and worsening after activity, possibly due to the immune system mistakenly attacking the body. Researchers are investigating immunoadsorption, a treatment that filters the blood to remove harmful antibodies, to see if it can improve fatigue and other symptoms in those with an autoimmune form of long COVID. Participants will be randomly assigned to one of two groups. One group will receive six sessions of immunoadsorption using tryptophan columns over two weeks, which remove specific antibodies from the blood. The other group will receive a placebo treatment of six sham sessions, where blood circulates through the system without antibody removal, also lasting 2.5 hours each over two weeks. During the study, participants will be assessed for changes in fatigue, quality of life, cognitive function, autonomic symptoms, and physical strength at multiple time points up to six months. Researchers will also monitor immunoglobulin levels, autoantibody scores, and any adverse events to understand the treatments effects and safety. The study includes a double-blind, placebo-controlled design to carefully evaluate immunoadsorption in long COVID patients with immune-related symptoms.

CONDITIONS

Brief Title

Immunoadsorption in Autoimmune Long COVID

Research Team

D

Daphne Schouten, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here